Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, J.-G.
Right arrow Articles by Liu-Chen, L.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, J.-G.
Right arrow Articles by Liu-Chen, L.-Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 17, 12087-12094, April 23, 1999

U50,488H-induced Internalization of the Human kappa  Opioid Receptor Involves a beta -Arrestin- and Dynamin-dependent Mechanism
kappa RECEPTOR INTERNALIZATION IS NOT REQUIRED FOR MITOGEN-ACTIVATED PROTEIN KINASE ACTIVATION

Jian-Guo Li, Lai-Yi Luo, Jason G. KrupnickDagger , Jeffrey L. BenovicDagger , and Lee-Yuan Liu-Chen

From the Department of Pharmacology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140 and the Dagger  Department of Microbiology and Immunology, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107

Agonist-promoted internalization of some G protein-coupled receptors has been shown to mediate receptor desensitization, resensitization, and down-regulation. In this study, we investigated whether opioids induced internalization of the human and rat kappa  opioid receptors stably expressed in Chinese hamster ovary cells, the potential mechanisms involved in this process and its possible role in activation of mitogen-activated protein (MAP) kinase. Exposure of the human kappa  receptor to the agonists U50,488H, U69,593, ethylketocyclazocine, or tifluadom, but not etorphine, promoted receptor internalization. However, none of these agonists induced significant internalization of the rat kappa  opioid receptor. U50,488H-induced human kappa  receptor internalization was time- and concentration-dependent, with 30-40% of the receptors internalized following a 30-min exposure to 1 µM U50,488H. Agonist removal resulted in the receptors gradually returning to the cell surface over a 60-min period. The antagonist naloxone blocked U50,488H-induced internalization without affecting internalization itself, while pretreatment with pertussis toxin had no effect on U50,488H-induced internalization. In contrast, incubation with sucrose (0.4-0.8 M) significantly reduced U50,488H-induced internalization of the kappa  receptor. While co-expression of the wild type GRK2, beta -arrestin, or dynamin I had no effect on kappa  receptor internalization, co-expression of the dominant negative mutants GRK2-K220R, beta -arrestin (319-418), or dynamin I-K44A significantly inhibited receptor internalization. Whether receptor internalization is critical for MAP kinase activation was next investigated. Co-expression of dominant negative mutants of beta -arrestin or dynamin I, which greatly reduced U50,488H-induced internalization, did not affect MAP kinase activation by the agonist. In addition, etorphine, which did not promote human kappa  receptor internalization, was able to fully activate MAP kinase. Moreover, U50,488H or etorphine stimulation of the rat kappa  receptor, which did not undergo internalization, also effectively activated MAP kinase. Thus, U50,488H-induced internalization of the human kappa  opioid receptor in Chinese hamster ovary cells occurs via a GRK-, beta -arrestin-, and dynamin I-dependent process that likely involves clathrin-coated pits. In addition, internalization of the kappa  receptor is not required for activation of MAP kinase.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
X. Xu, V. A. Kanda, E. Choi, G. Panaghie, T. K. Roepke, S. A. Gaeta, D. J. Christini, D. J. Lerner, and G. W. Abbott
MinK-dependent internalization of the IKs potassium channel
Cardiovasc Res, June 1, 2009; 82(3): 430 - 438.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J.-G. Li, D. S. Haines, and L.-Y. Liu-Chen
Agonist-Promoted Lys63-Linked Polyubiquitination of the Human {kappa}-Opioid Receptor Is Involved in Receptor Down-Regulation
Mol. Pharmacol., April 1, 2008; 73(4): 1319 - 1330.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Wang, Y. Chen, W. Xu, D. Y.W. Lee, Z. Ma, S. M. Rawls, A. Cowan, and L.-Y. Liu-Chen
2-Methoxymethyl-Salvinorin B Is a Potent {kappa} Opioid Receptor Agonist with Longer Lasting Action in Vivo Than Salvinorin A
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1073 - 1083.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Wang, A. Bisello, Y. Yang, G. G. Romero, and P. A. Friedman
NHERF1 Regulates Parathyroid Hormone Receptor Membrane Retention without Affecting Recycling
J. Biol. Chem., December 14, 2007; 282(50): 36214 - 36222.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Chen, C. Chen, Y. Wang, and L.-Y. Liu-Chen
Ligands Regulate Cell Surface Level of the Human {kappa} Opioid Receptor by Activation-Induced Down-Regulation and Pharmacological Chaperone-Mediated Enhancement: Differential Effects of Nonpeptide and Peptide Agonists
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 765 - 775.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Xu, S.-I. Yoon, P. Huang, Y. Wang, C. Chen, P. L.-G. Chong, and L.-Y. Liu-Chen
Localization of the {kappa} Opioid Receptor in Lipid Rafts
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1295 - 1306.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Zhao, H. H. Loh, and P. Y. Law
Adenylyl Cyclase Superactivation Induced by Long-Term Treatment with Opioid Agonist Is Dependent on Receptor Localized within Lipid Rafts and Is Independent of Receptor Internalization
Mol. Pharmacol., April 1, 2006; 69(4): 1421 - 1432.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Chen, J.-G. Li, Y. Chen, P. Huang, Y. Wang, and L.-Y. Liu-Chen
GEC1 Interacts with the {kappa} Opioid Receptor and Enhances Expression of the Receptor
J. Biol. Chem., March 24, 2006; 281(12): 7983 - 7993.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Wang, K. Tang, S. Inan, D. Siebert, U. Holzgrabe, D. Y.W. Lee, P. Huang, J.-G. Li, A. Cowan, and L.-Y. Liu-Chen
Comparison of Pharmacological Activities of Three Distinct {kappa} Ligands (Salvinorin A, TRK-820 and 3FLB) on {kappa} Opioid Receptors in Vitro and Their Antipruritic and Antinociceptive Activities in Vivo
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 220 - 230.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
I. Tegeder and G. Geisslinger
Opioids As Modulators of Cell Death and Survival--Unraveling Mechanisms and Revealing New Indications
Pharmacol. Rev., September 1, 2004; 56(3): 351 - 369.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. H. Brown and C. W. Bourque
Autocrine feedback inhibition of plateau potentials terminates phasic bursts in magnocellular neurosecretory cells of the rat supraoptic nucleus
J. Physiol., June 15, 2004; 557(3): 949 - 960.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. P. McLaughlin, L. C. Myers, P. E. Zarek, M. G. Caron, R. J. Lefkowitz, T. A. Czyzyk, J. E. Pintar, and C. Chavkin
Prolonged Kappa Opioid Receptor Phosphorylation Mediated by G-protein Receptor Kinase Underlies Sustained Analgesic Tolerance
J. Biol. Chem., January 16, 2004; 279(3): 1810 - 1818.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Wang, J.-G. Li, P. Huang, W. Xu, and L.-Y. Liu-Chen
Differential Effects of Agonists on Adenylyl Cyclase Superactivation Mediated by the {kappa} Opioid Receptors: Adenylyl Cyclase Superactivation Is Independent of Agonist-Induced Phosphorylation, Desensitization, Internalization, and Down-Regulation
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1127 - 1134.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Wang, H. H. Loh, and P.-Y. Law
The Intracellular Trafficking of Opioid Receptors Directed by Carboxyl Tail and a Di-leucine Motif in Neuro2A Cells
J. Biol. Chem., September 19, 2003; 278(38): 36848 - 36858.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. P. McLaughlin, M. Xu, K. Mackie, and C. Chavkin
Phosphorylation of a Carboxyl-terminal Serine within the {kappa}-Opioid Receptor Produces Desensitization and Internalization
J. Biol. Chem., September 5, 2003; 278(36): 34631 - 34640.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Marie, I. Lecoq, P. Jauzac, and S. Allouche
Differential Sorting of Human {delta}-Opioid Receptors after Internalization by Peptide and Alkaloid Agonists
J. Biol. Chem., June 13, 2003; 278(25): 22795 - 22804.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J.-G. Li, F. Zhang, X.-L. Jin, and L.-Y. Liu-Chen
Differential Regulation of the Human kappa Opioid Receptor by Agonists: Etorphine and Levorphanol Reduced Dynorphin A- and U50,488H-Induced Internalization and Phosphorylation
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 531 - 540.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. J. Gerdin, M. I. Masana, D. Ren, R. J. Miller, and M. L. Dubocovich
Short-Term Exposure to Melatonin Differentially Affects the Functional Sensitivity and Trafficking of the hMT1 and hMT2 Melatonin Receptors
J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 931 - 939.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. A. Eisinger, H. Ammer, and R. Schulz
Chronic Morphine Treatment Inhibits Opioid Receptor Desensitization and Internalization
J. Neurosci., December 1, 2002; 22(23): 10192 - 10200.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Zhang, J. Li, J.-G. Li, and L.-Y. Liu-Chen
(-)U50,488H [(trans)-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] Induces Internalization and Down-Regulation of the Human, but not the Rat, kappa -Opioid Receptor: Structural Basis for the Differential Regulation
J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1184 - 1192.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
P. J. Dolph
Book Review: Arrestin: Roles in the Life and Death of Retinal Neurons
Neuroscientist, August 1, 2002; 8(4): 347 - 355.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
J.-G. Li, C. Chen, and L.-Y. Liu-Chen
Ezrin-Radixin-Moesin-binding Phosphoprotein-50/Na+/H+ Exchanger Regulatory Factor (EBP50/NHERF) Blocks U50,488H-induced Down-regulation of the Human kappa Opioid Receptor by Enhancing Its Recycling Rate
J. Biol. Chem., July 19, 2002; 277(30): 27545 - 27552.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Schulz, A. Wehmeyer, and K. Schulz
Visualizing Preference of G Protein-Coupled Receptor Kinase 3 for the Process of kappa -Opioid Receptor Sequestration
Mol. Pharmacol., June 1, 2002; 61(6): 1444 - 1452.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. H. Shah, J. Alberto Olivares-Reyes, A. Yesilkaya, and K. J. Catt
Independence of Angiotensin II-Induced MAP Kinase Activation from Angiotensin Type 1 Receptor Internalization in Clone 9 Hepatocytes
Mol. Endocrinol., March 1, 2002; 16(3): 610 - 620.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Li, J.-G. Li, C. Chen, F. Zhang, and L.-Y. Liu-Chen
Molecular Basis of Differences in (-)(trans)-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-Induced Desensitization and Phosphorylation between Human and Rat kappa -Opioid Receptors Expressed in Chinese Hamster Ovary Cells
Mol. Pharmacol., January 1, 2002; 61(1): 73 - 84.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Hilairet, C. Belanger, J. Bertrand, A. Laperriere, S. M. Foord, and M. Bouvier
Agonist-promoted Internalization of a Ternary Complex between Calcitonin Receptor-like Receptor, Receptor Activity-modifying Protein 1 (RAMP1), and beta -Arrestin
J. Biol. Chem., November 2, 2001; 276(45): 42182 - 42190.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Smith, R. Yu, and P. M. Hinkle
Activation of MAPK by TRH Requires Clathrin-Dependent Endocytosis and PKC but Not Receptor Interaction with {beta}-Arrestin or Receptor Endocytosis
Mol. Endocrinol., September 1, 2001; 15(9): 1539 - 1548.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Cen, Y. Xiong, L. Ma, and G. Pei
Direct and Differential Interaction of {beta}-Arrestins with the Intracellular Domains of Different Opioid Receptors
Mol. Pharmacol., April 1, 2001; 59(4): 758 - 764.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
S. S. G. Ferguson
Evolving Concepts in G Protein-Coupled Receptor Endocytosis: The Role in Receptor Desensitization and Signaling
Pharmacol. Rev., March 1, 2001; 53(1): 1 - 24.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J.-G. Li, J. L. Benovic, and L.-Y. Liu-Chen
Mechanisms of Agonist-Induced Down-Regulation of the Human kappa -Opioid Receptor: Internalization Is Required for Down-Regulation
Mol. Pharmacol., October 1, 2000; 58(4): 795 - 801.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Inoue and H. Ueda
Protein Kinase C-Mediated Acute Tolerance to Peripheral {micro}-Opioid Analgesia in the Bradykinin-Nociception Test in Mice
J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 662 - 669.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Maudsley, K. L. Pierce, A. M. Zamah, W. E. Miller, S. Ahn, Y. Daaka, R. J. Lefkowitz, and L. M. Luttrell
The beta 2-Adrenergic Receptor Mediates Extracellular Signal-regulated Kinase Activation via Assembly of a Multi-receptor Complex with the Epidermal Growth Factor Receptor
J. Biol. Chem., March 24, 2000; 275(13): 9572 - 9580.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. A. Zaki, D. E. Keith Jr., G. A. Brine, F. I. Carroll, and C. J. Evans
Ligand-Induced Changes in Surface {micro}-Opioid Receptor Number: Relationship to G Protein Activation?
J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1127 - 1134.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
G. Ferguson, K. R. Watterson, and T. M. Palmer
Subtype-Specific Kinetics of Inhibitory Adenosine Receptor Internalization Are Determined by Sensitivity to Phosphorylation by G Protein-Coupled Receptor Kinases
Mol. Pharmacol., March 1, 2000; 57(3): 546 - 552.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. L. Pierce, S. Maudsley, Y. Daaka, L. M. Luttrell, and R. J. Lefkowitz
Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors
PNAS, February 15, 2000; 97(4): 1489 - 1494.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z.-J. Cheng, J. Zhao, Y. Sun, W. Hu, Y.-L. Wu, B. Cen, G.-X. Wu, and G. Pei
beta -Arrestin Differentially Regulates the Chemokine Receptor CXCR4-mediated Signaling and Receptor Internalization, and This Implicates Multiple Interaction Sites between beta -Arrestin and CXCR4
J. Biol. Chem., January 28, 2000; 275(4): 2479 - 2485.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Whistler and M. von Zastrow
Dissociation of Functional Roles of Dynamin in Receptor-mediated Endocytosis and Mitogenic Signal Transduction
J. Biol. Chem., August 27, 1999; 274(35): 24575 - 24578.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Laporte, R. H. Oakley, J. A. Holt, L. S. Barak, and M. G. Caron
The Interaction of beta -Arrestin with the AP-2 Adaptor Is Required for the Clustering of beta 2-Adrenergic Receptor into Clathrin-coated Pits
J. Biol. Chem., July 21, 2000; 275(30): 23120 - 23126.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-K. Tong, N. K. Hussain, A. G. Adams, J. P. O'Bryan, and P. S. McPherson
Intersectin Can Regulate the Ras/MAP Kinase Pathway Independent of Its Role in Endocytosis
J. Biol. Chem., September 15, 2000; 275(38): 29894 - 29899.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Xiang, G.-H. Yu, J. Guo, L. Chen, W. Hu, G. Pei, and L. Ma
Heterologous Activation of Protein Kinase C Stimulates Phosphorylation of delta -Opioid Receptor at Serine 344, Resulting in beta -Arrestin- and Clathrin-mediated Receptor Internalization
J. Biol. Chem., February 9, 2001; 276(7): 4709 - 4716.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Schmidlin, O. Dery, K. O. DeFea, L. Slice, S. Patierno, C. Sternini, E. F. Grady, and N. W. Bunnett
Dynamin and Rab5a-dependent Trafficking and Signaling of the Neurokinin 1 Receptor
J. Biol. Chem., June 29, 2001; 276(27): 25427 - 25437.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. B. Penn, R. M. Pascual, Y.-M. Kim, S. J. Mundell, V. P. Krymskaya, R. A. Panettieri Jr., and J. L. Benovic
Arrestin Specificity for G Protein-coupled Receptors in Human Airway Smooth Muscle
J. Biol. Chem., August 24, 2001; 276(35): 32648 - 32656.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement